MedTrace Logo

Diagnostic Performance of Exome Sequencing in Autism Spectrum Disorders

NCT04043351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-06-03

No results posted yet for this study

Summary

Evaluation of the diagnostic performance of exome sequencing in a prospective series of patients with autism spectrum disorders (ASD).

Conditions

Interventions

BIOLOGICAL

blood test

Performing exome sequencing in addition to the standard clinical workup, using DNA extracted from a blood sample collected as part of the patient's standard clinical workup * Interpretation of genetic variations identified in the exome that affect genes on the pre-established list; potential use of parental samples for segregation analysis to aid in the interpretation of the patient's variations * Preparation of a research report following any necessary clinical-biological comparison

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • GAEL NICOLAS · ROUEN HOSPITAL

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-12
Primary Completion
2021-10-19
Completion
2021-10-19

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04043351 on ClinicalTrials.gov